908 Devices (NASDAQ:MASS) SVP Kevin Mccallion Sells 2,693 Shares

Key Points

• SVP Kevin Mccallion sold 2,693 shares on April 10 at an average price of $7.01 under a pre-arranged Rule 10b5-1 plan, trimming his stake by 5.66% to 44,925 shares (≈$314,924).
• MASS shares traded up 1.7% to $7.32, with a market cap of $273.6M, a P/E of 13.31, a 12‑month range of $4.14–$9.34, and 50/200‑day SMAs of $6.49/$6.65.
• 908 Devices slightly beat quarterly expectations (EPS $(0.05) vs. $(0.06) est.; revenue $17.38M vs. $16.19M), but analysts are mixed with a consensus "Hold" and a $12 target while full‑year EPS is forecast at -1.99.

908 Devices Inc. (NASDAQ:MASS - Get Free Report) SVP Kevin Mccallion sold 2,693 shares of the stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $7.01, for a total value of $18,877.93. Following the transaction, the senior vice president owned 44,925 shares in the company, valued at approximately $314,924.25. This trade represents a 5.66% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Up 1.7%

MASS stock traded up $0.12 during midday trading on Tuesday, hitting $7.32. 247,422 shares of the company traded hands, compared to its average volume of 308,215. 908 Devices Inc. has a twelve month low of $4.14 and a twelve month high of $9.34. The stock has a market capitalization of $273.62 million, a price-to-earnings ratio of 13.31 and a beta of 0.54. The business has a 50 day simple moving average of $6.49 and a 200-day simple moving average of $6.65.

908 Devices (NASDAQ:MASS - Get Free Report) last posted its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01. 908 Devices had a negative return on equity of 14.99% and a net margin of 34.68%.The company had revenue of $17.38 million during the quarter, compared to analysts' expectations of $16.19 million. Equities research analysts forecast that 908 Devices Inc. will post -1.99 EPS for the current year.

Wall Street Analysts Forecast Growth

MASS has been the subject of several research reports. Weiss Ratings reissued a "sell (d-)" rating on shares of 908 Devices in a research report on Wednesday, January 21st. Wall Street Zen raised 908 Devices from a "hold" rating to a "buy" rating in a research report on Saturday, March 14th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $12.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. First Eagle Investment Management LLC lifted its position in 908 Devices by 125.9% in the third quarter. First Eagle Investment Management LLC now owns 603,962 shares of the company's stock worth $5,291,000 after purchasing an additional 336,584 shares during the period. First Light Asset Management LLC lifted its position in 908 Devices by 135.2% in the third quarter. First Light Asset Management LLC now owns 2,510,496 shares of the company's stock worth $21,992,000 after purchasing an additional 1,442,883 shares during the period. FourThought Financial Partners LLC bought a new position in 908 Devices in the third quarter worth $327,000. HighMark Wealth Management LLC bought a new position in 908 Devices in the fourth quarter worth $1,265,000. Finally, Strs Ohio lifted its position in 908 Devices by 130.2% in the fourth quarter. Strs Ohio now owns 29,700 shares of the company's stock worth $156,000 after purchasing an additional 16,800 shares during the period. 88.06% of the stock is owned by institutional investors.

About 908 Devices

908 Devices Inc NASDAQ: MASS is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.